Osteopore Limited (ASX:OSX)

Market Cap	2.85M
Revenue (ttm)	2.85M
Net Income (ttm)	-3.36M
Shares Out	237.26M
EPS (ttm)	-0.03
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,126,542
Average Volume	2,906,915
Open	0.0110
Previous Close	0.0100
Day's Range	0.0100 - 0.0120
52-Week Range	0.0080 - 0.0480
Beta	-0.37
RSI	55.33
Earnings Date	Aug 29, 2025

About Osteopore

Osteopore Limited, a regenerative medicine company, engages in the production of 3D-printed biomimetic and bioresorbable implants in Vietnam, South Korea, the Philippines, Singapore, India, Malaysia, the Netherlands, Thailand, Australia, and internationally. The company commercializes products designed to enable natural bone healing across multiple therapeutic areas. Its technology fabricates specific micro-structured scaffolds for bone regeneration through 3D printing and bioresorbable material. The company manufactures and trades medical impl...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 2003
• Country: Australia
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: OSX

Financial Performance

In 2024, Osteopore's revenue was 2.76 million, an increase of 24.60% compared to the previous year's 2.22 million. Losses were -3.35 million, -31.19% less than in 2023.